Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study

Tadashi Yokoyama; Akihiko Ohta; Satoshi Motoya; Masakazu Takazoe; Toshitaka Yajima; Masataka Date; Masahiro Nii; Péter Nagy; Yasuo Suzuki; Toshifumi Hibi

doi:10.1159/000484047

Efficacy and Safety of Oral Budesonide in Patients with Active Crohn's Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study

Inflammatory Intestinal Diseases ◽

10.1159/000484047 ◽

2017 ◽

Vol 2 (3) ◽

pp. 154-162 ◽

Cited By ~ 5

Author(s):

Tadashi Yokoyama ◽

Akihiko Ohta ◽

Satoshi Motoya ◽

Masakazu Takazoe ◽

Toshitaka Yajima ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Parallel Group

Download Full-text

Efficacy and safety of biosimilar CT-P13 compared with originator infliximab in patients with active Crohn's disease: an international, randomised, double-blind, phase 3 non-inferiority study

The Lancet ◽

10.1016/s0140-6736(18)32196-2 ◽

2019 ◽

Vol 393 (10182) ◽

pp. 1699-1707 ◽

Cited By ~ 40

Author(s):

Byong Duk Ye ◽

Marina Pesegova ◽

Olga Alexeeva ◽

Marina Osipenko ◽

Adi Lahat ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of sirukumab in patients with active rheumatoid arthritis refractory to anti-TNF therapy (SIRROUND-T): a randomised, double-blind, placebo-controlled, parallel-group, multinational, phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727328077.793564275 ◽

2019 ◽

Author(s):

Ladislav Senolt

Keyword(s):

Rheumatoid Arthritis ◽

Active Rheumatoid Arthritis ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

Efficacy and Safety of the Biosimilar IBI301 Plus Standard CHOP (I-CHOP) in Comparison With Rituximab Plus CHOP (R-CHOP) in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (DLBCL): A Randomized, Double-Blind, Parallel-Group, Phase 3 Trial

Advances in Therapy ◽

10.1007/s12325-020-01603-8 ◽

2021 ◽

Vol 38 (4) ◽

pp. 1889-1903

Author(s):

Yuqin Song ◽

Hui Zhou ◽

Huilai Zhang ◽

Wei Liu ◽

Yuerong Shuang ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Large B Cell Lymphoma ◽

Parallel Group ◽

Large B Cell

Download Full-text

Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial

The Lancet Gastroenterology & Hepatology ◽

10.1016/s2468-1253(21)00252-1 ◽

2021 ◽

Author(s):

Stephen Hanauer ◽

Bernd Liedert ◽

Sigrid Balser ◽

Ekkehard Brockstedt ◽

Viktoria Moschetti ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Reference Product ◽

Phase 3 ◽

Double Blind ◽

Safety And Efficacy

Download Full-text

Phase 3, single-center, sequential and parallel-group, double-blind, randomized study evaluating the efficacy and safety of Fexofenadine Hydrochloride 180 mg (Allegra®/Telfast®) versus placebo in subjects suffering from Allergic Rhinitis with symptoms aggravated in presence of pollutants: analysis of individual symptom scores

World Allergy Organization Journal ◽

10.1016/j.waojou.2020.100266 ◽

2020 ◽

Vol 13 (8) ◽

pp. 100266

Author(s):

Anne K. Ellis ◽

Margarita Murrieta-Aguttes ◽

Sandy Furey ◽

Christopher Carlsten

Keyword(s):

Allergic Rhinitis ◽

Randomized Study ◽

Efficacy And Safety ◽

Single Center ◽

Phase 3 ◽

Double Blind ◽

Parallel Group ◽

Symptom Scores

Download Full-text

Faculty Opinions recommendation of Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.741267002.793590492 ◽

2021 ◽

Author(s):

Pedro Legua Leiva

Keyword(s):

Randomised Controlled Trial ◽

Controlled Trial ◽

Trichuris Trichiura ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

School Aged Children ◽

Pemba Island ◽

Parallel Group ◽

Randomised Controlled

Download Full-text

Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(18)30426-0 ◽

2019 ◽

Vol 7 (3) ◽

pp. 249-259 ◽

Cited By ~ 43

Author(s):

Florian von Groote-Bidlingmaier ◽

Ramonde Patientia ◽

Epifanio Sanchez ◽

Vincent Balanag ◽

Eduardo Ticona ◽

...

Keyword(s):

Multidrug Resistant ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Resistant Tuberculosis ◽

Multidrug Resistant Tuberculosis ◽

Background Regimen ◽

Parallel Group

Download Full-text

Clinical Trial Protocol: Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy, and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults with Aneurysmal Subarachnoid Hemorrhage [NEWTON-2 (Nimodipine Microparticles to Enhance Recovery While Reducing TOxicity After SubarachNoid Hemorrhage)]

Neurocritical Care ◽

10.1007/s12028-018-0575-z ◽

2018 ◽

Vol 30 (1) ◽

pp. 88-97 ◽

Cited By ~ 17

Author(s):

Daniel Hänggi ◽

◽

Nima Etminan ◽

Stephan A. Mayer ◽

E. Francois Aldrich ◽

...

Keyword(s):

Subarachnoid Hemorrhage ◽

Aneurysmal Subarachnoid Hemorrhage ◽

Standard Of Care ◽

Efficacy And Safety ◽

Safety Study ◽

Phase 3 ◽

Double Blind ◽

Group Efficacy ◽

Double Blind Placebo ◽

Parallel Group

Download Full-text

Efficacy and safety of revefenacin (REV), a long-acting muscarinic antagonist for nebulization: results of replicate randomized, double-blind, placebo-controlled, parallel-group phase 3 trials in participants with moderate to very severe COPD

10.1183/1393003.congress-2017.pa1812 ◽

2017 ◽

Author(s):

Gary Ferguson ◽

Krishna K. Pudi ◽

Gregory Feldmann ◽

Srikanth Pendyala ◽

Chris N. Barnes ◽

...

Keyword(s):

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Muscarinic Antagonist ◽

Double Blind Placebo ◽

Parallel Group ◽

Long Acting ◽

Severe Copd

Download Full-text

Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study

Sleep Medicine ◽

10.1016/j.sleep.2013.07.007 ◽

2013 ◽

Vol 14 (11) ◽

pp. 1085-1091 ◽

Cited By ~ 13

Author(s):

Yuichi Inoue ◽

Tetsuo Shimizu ◽

Koichi Hirata ◽

Naohisa Uchimura ◽

Jun Ishigooka ◽

...

Keyword(s):

Restless Legs Syndrome ◽

Japanese Patients ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Restless Legs ◽

Parallel Group Study ◽

Parallel Group

Download Full-text